CD27 Promotes Survival of Activated T Cells and Complements CD28 in Generation and Establishment of the Effector T Cell Pool

Overview

Journal J Exp Med

Specialties Allergy & Immunology
General Medicine

Date 2003 Oct 29

PMID 14581610

Citations 174

Authors

Jenny Hendriks

Yanling Xiao

Jannie Borst

Affiliations

Soon will be listed here.

Abstract

CD27, like CD28, acts in concert with the T cell receptor to support T cell expansion. Using CD27(-/-) mice, we have shown earlier that CD27 determines the magnitude of primary and memory T cell responses to influenza virus. Here, we have examined the relative contributions of CD27 and CD28 to generation of the virus-specific effector T cell pool and its establishment at the site of infection (the lung), using CD27(-/-), CD28(-/-), and CD27/CD28(-/-) mice. We find that primary and memory CD8+ T cell responses to influenza virus are dependent on the collective contribution of both receptors. In the primary response, CD27 and CD28 impact to a similar extent on expansion of virus-specific T cells in draining lymph nodes. CD27 is the principle determinant for accumulation of virus-specific T cells in the lung because it can sustain this response in CD28(-/-) mice. Unlike CD28, CD27 does not affect cell cycle activity, but promotes survival of activated T cells throughout successive rounds of division at the site of priming and may do so at the site of infection as well. CD27 was found to rescue CD28(-/-) T cells from death at the onset of division, explaining its capacity to support a T cell response in absence of CD28.

Citing Articles

HLA-E-restricted Hantaan virus-specific CD8 T cell responses enhance the control of infection in hemorrhagic fever with renal syndrome.

Tang K, Zhang Y, Li X, Zhang C, Jia X, Hu H Biosaf Health. 2025; 5(5):289-299.

PMID: 40078905 PMC: 11895001. DOI: 10.1016/j.bsheal.2023.06.002.

Distinct immune profiles in children living with HIV based on timing and duration of suppressive antiretroviral treatment.

Lee M, Litchford M, Vendrame E, Vergara R, Ranganath T, Fish C Virology. 2024; 602:110318.

PMID: 39612623 PMC: 11645197. DOI: 10.1016/j.virol.2024.110318.

Advances and prospects in tumor infiltrating lymphocyte therapy.

Qiu X, Li S, Fan T, Zhang Y, Wang B, Zhang B Discov Oncol. 2024; 15(1):630.

PMID: 39514075 PMC: 11549075. DOI: 10.1007/s12672-024-01410-5.

Azithromycin targets the CD27 pathway to modulate CD27hi T-lymphocyte expansion and type-1 effector phenotype.

Ansari A, Jayakumar M, Ahmad F, Venkatachalam T, Salameh L, Unnikannan H Front Immunol. 2024; 15:1447625.

PMID: 39211048 PMC: 11357905. DOI: 10.3389/fimmu.2024.1447625.

Enhancing the Efficacy of CAR-T Cell Therapy: A Comprehensive Exploration of Cellular Strategies and Molecular Dynamics.

Baysal M, Chakraborty A, Tsimberidou A J Cancer Immunol (Wilmington). 2024; 6(1):20-28.

PMID: 39119270 PMC: 11308461. DOI: 10.33696/cancerimmunol.6.080.

References

Haanen J, Wolkers M, Kruisbeek A, Schumacher T . Selective expansion of cross-reactive CD8(+) memory T cells by viral variants. J Exp Med. 1999; 190(9):1319-28. PMC: 2195685. DOI: 10.1084/jem.190.9.1319. View

Tan J, Whitmire J, Ahmed R, Pearson T, Larsen C . 4-1BB ligand, a member of the TNF family, is important for the generation of antiviral CD8 T cell responses. J Immunol. 1999; 163(9):4859-68. View

Kopf M, Ruedl C, Schmitz N, Gallimore A, Lefrang K, Ecabert B . OX40-deficient mice are defective in Th cell proliferation but are competent in generating B cell and CTL Responses after virus infection. Immunity. 2000; 11(6):699-708. DOI: 10.1016/s1074-7613(00)80144-2. View

Dahl A, Klein C, Andres P, London C, Lodge M, Mulligan R . Expression of bcl-X(L) restores cell survival, but not proliferation off effector differentiation, in CD28-deficient T lymphocytes. J Exp Med. 2000; 191(12):2031-8. PMC: 2193206. DOI: 10.1084/jem.191.12.2031. View

Locksley R, Killeen N, Lenardo M . The TNF and TNF receptor superfamilies: integrating mammalian biology. Cell. 2001; 104(4):487-501. DOI: 10.1016/s0092-8674(01)00237-9. View

Hendriks J, Gravestein L, Tesselaar K, van Lier R, Schumacher T, Borst J . CD27 is required for generation and long-term maintenance of T cell immunity. Nat Immunol. 2001; 1(5):433-40. DOI: 10.1038/80877. View

Okkenhaug K, Wu L, Garza K, La Rose J, Khoo W, Odermatt B . A point mutation in CD28 distinguishes proliferative signals from survival signals. Nat Immunol. 2001; 2(4):325-32. DOI: 10.1038/86327. View

Micheau O, Lens S, Gaide O, Alevizopoulos K, Tschopp J . NF-kappaB signals induce the expression of c-FLIP. Mol Cell Biol. 2001; 21(16):5299-305. PMC: 87253. DOI: 10.1128/MCB.21.16.5299-5305.2001. View

ROGERS P, Song J, Gramaglia I, Killeen N, Croft M . OX40 promotes Bcl-xL and Bcl-2 expression and is essential for long-term survival of CD4 T cells. Immunity. 2001; 15(3):445-55. DOI: 10.1016/s1074-7613(01)00191-1. View

10.

Suresh M, Whitmire J, Harrington L, Larsen C, Pearson T, Altman J . Role of CD28-B7 interactions in generation and maintenance of CD8 T cell memory. J Immunol. 2001; 167(10):5565-73. DOI: 10.4049/jimmunol.167.10.5565. View

11.

Arens R, Tesselaar K, Baars P, van Schijndel G, Hendriks J, Pals S . Constitutive CD27/CD70 interaction induces expansion of effector-type T cells and results in IFNgamma-mediated B cell depletion. Immunity. 2001; 15(5):801-12. DOI: 10.1016/s1074-7613(01)00236-9. View

12.

Cooper D, Bansal-Pakala P, Croft M . 4-1BB (CD137) controls the clonal expansion and survival of CD8 T cells in vivo but does not contribute to the development of cytotoxicity. Eur J Immunol. 2002; 32(2):521-9. DOI: 10.1002/1521-4141(200202)32:2<521::AID-IMMU521>3.0.CO;2-X. View

13.

Futagawa T, Akiba H, Kodama T, Takeda K, Hosoda Y, Yagita H . Expression and function of 4-1BB and 4-1BB ligand on murine dendritic cells. Int Immunol. 2002; 14(3):275-86. DOI: 10.1093/intimm/14.3.275. View

14.

Bertram E, Lau P, Watts T . Temporal segregation of 4-1BB versus CD28-mediated costimulation: 4-1BB ligand influences T cell numbers late in the primary response and regulates the size of the T cell memory response following influenza infection. J Immunol. 2002; 168(8):3777-85. DOI: 10.4049/jimmunol.168.8.3777. View

15.

Halstead E, Mueller Y, Altman J, Katsikis P . In vivo stimulation of CD137 broadens primary antiviral CD8+ T cell responses. Nat Immunol. 2002; 3(6):536-41. DOI: 10.1038/ni798. View

16.

Roman E, Miller E, Harmsen A, Wiley J, von Andrian U, Huston G . CD4 effector T cell subsets in the response to influenza: heterogeneity, migration, and function. J Exp Med. 2002; 196(7):957-68. PMC: 2194021. DOI: 10.1084/jem.20021052. View

17.

Tesselaar K, Xiao Y, Arens R, van Schijndel G, Schuurhuis D, Mebius R . Expression of the murine CD27 ligand CD70 in vitro and in vivo. J Immunol. 2002; 170(1):33-40. DOI: 10.4049/jimmunol.170.1.33. View

18.

Tesselaar K, Arens R, van Schijndel G, Baars P, van der Valk M, Borst J . Lethal T cell immunodeficiency induced by chronic costimulation via CD27-CD70 interactions. Nat Immunol. 2002; 4(1):49-54. DOI: 10.1038/ni869. View

19.

van Lier R, Borst J, Vroom T, Klein H, van Mourik P, Zeijlemaker W . Tissue distribution and biochemical and functional properties of Tp55 (CD27), a novel T cell differentiation antigen. J Immunol. 1987; 139(5):1589-96. View

20.

Teh H, Kisielow P, Scott B, Kishi H, Uematsu Y, Bluthmann H . Thymic major histocompatibility complex antigens and the alpha beta T-cell receptor determine the CD4/CD8 phenotype of T cells. Nature. 1988; 335(6187):229-33. DOI: 10.1038/335229a0. View